The goal of the study is to find a correlation between FIRM targeted sites and micro-anatomic fibrotic tracks. Patients will first undergo a contrast-enhanced MRI scan to provide a 3-dimensional image of the left and right atria, and will then be observed using an MRI machine to determine the correlation.
20 subjects will be enrolled in the study. The primary purpose of the trial is observation. The study began on November 3, 2016 and is estimated to be completed by November 3, 2020.
- Patients who have symptomatic paroxysmal or persistent atrial fibrillation and are currently undergoing clinically-indicated ablation procedures utilizing FIRM mapping with pre-operative MRI.
- Volunteers for the study must be at least 18 years of age.
- LAA thrombus detected on pre-procedure TEE
- Patient unable to receive MRI scan
- Patient unable to receive gadolinium contrast
The study will take place at Ohio State University, Columbus, Ohio, United States, 43210. If you have any questions, please contact Adrianne Miller, RN at 614-685-4394 / Adrianne.Miller@osumc.edu, or Julie Ryan at 614-685-4394 / Julie.Ryan@osumc.edu.
Sponsors / Collaborators
The study is sponsored by the Ohio State University and directed by Deanna Golden-Kreutz, RN, Phd.
View All Clinical TrialsClinical Trials
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
This study aims to survey patients with atrial fibrillation in order to understand direct-acting oral anticoagulant (DOAC) treatment from the…
iCLAS for Persistent Atrial Fibrillation
This study aims to evaluate the safety of the Adagio AF Cryoablation System (iCLAS™) for ablation treatment of persistent atrial fibrillation.…
Esophageal Deviation in Atrial Fibrillation Ablation
Ablation treatment in the posterior wall of the left atrium can cause thermal injury to the esophagus, which is a very common occurrence. The goal…
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter
The goal of this study is to compare heart rate control (heart rate <110 beats per minute) at 2 hours after taking the medication diltiazem…
Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
The goal of this study is to determine the long term success of non-paroxysmal ablation to treat atrial fibrillation using three different…
The Genetic Basis for Atrial Fibrillation
Veteran patients with atrial fibrillation will be examined for common genetic polymorphisms, and identify…
Liraglutide Effect in Atrial Fibrillation
The goal of this study is to use a medication called Liraglutide to reduce fat deposits surrounding the heart, and…